|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM097009741 |
003 |
DE-627 |
005 |
20250131202352.0 |
007 |
tu |
008 |
231222s1998 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0324.xml
|
035 |
|
|
|a (DE-627)NLM097009741
|
035 |
|
|
|a (NLM)9762443
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Metzker, M L
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Quantitation of mixed-base populations of HIV-1 variants by automated DNA sequencing with BODIPY dye-labeled primers
|
264 |
|
1 |
|c 1998
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 25.11.1998
|
500 |
|
|
|a Date Revised 21.11.2008
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Direct DNA sequencing of human immunodeficiency virus type 1 (HIV-1) pol and env gene regions was characterized for accuracy and precision. Restricted maximum likelihood (REML) analysis of molecular clone reconstruction experiments using a primer-walking strategy showed that the BODIPY and BODIPY energy-transfer (BET) dye primers sets were significantly more accurate in quantitating heterogenous base mixtures than the fluorescein/rhodamine dye primers. Of the three sets examined, the BET dye primers were the most accurate. The improved accuracy correlated with the reduced emission band-widths of BODIPY and BET dye primers and the more uniform signal intensities of BET dye primers. However, comparing % coefficients of variation (CV) for the three dye primer sets, revealed that BODIPY dye primers gave better precision than both BET and fluorescein/rhodamine dye primer sets. Several sequence-dependent motifs were identified that showed specific nucleotide-biased incorporation and were determined to be the major variable component of the total %CV. Taken together, these results show that BODIPY and BET direct DNA sequencing can accurately and precisely characterize complex mixed-base populations
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
|2 NLM
|
650 |
|
7 |
|a Boron Compounds
|2 NLM
|
650 |
|
7 |
|a DNA Primers
|2 NLM
|
650 |
|
7 |
|a DNA, Viral
|2 NLM
|
650 |
|
7 |
|a HIV Envelope Protein gp120
|2 NLM
|
650 |
|
7 |
|a DNA-Directed DNA Polymerase
|2 NLM
|
650 |
|
7 |
|a EC 2.7.7.7
|2 NLM
|
700 |
1 |
|
|a Ansari-Lari, M A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, X M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Holder, D J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gibbs, R A
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1993
|g 25(1998), 3 vom: 07. Sept., Seite 446-7, 450-2, 454, passim
|w (DE-627)NLM012627046
|x 0736-6205
|7 nnns
|
773 |
1 |
8 |
|g volume:25
|g year:1998
|g number:3
|g day:07
|g month:09
|g pages:446-7, 450-2, 454, passim
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_99
|
912 |
|
|
|a GBV_ILN_121
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_618
|
912 |
|
|
|a GBV_ILN_640
|
912 |
|
|
|a GBV_ILN_754
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2002
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2023
|
912 |
|
|
|a GBV_ILN_2035
|
912 |
|
|
|a GBV_ILN_2040
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2099
|
912 |
|
|
|a GBV_ILN_2105
|
912 |
|
|
|a GBV_ILN_2121
|
912 |
|
|
|a GBV_ILN_2470
|
951 |
|
|
|a AR
|
952 |
|
|
|d 25
|j 1998
|e 3
|b 07
|c 09
|h 446-7, 450-2, 454, passim
|